Literature DB >> 11676571

Biosynthetic pathway of cephabacins in Lysobacter lactamgenus: molecular and biochemical characterization of the upstream region of the gene clusters for engineering of novel antibiotics.

Y S Sohn1, D H Nam, D D Ryu.   

Abstract

The cephabacins, one of the beta-lactam antibiotics, are produced by Lysobacter lactamgenus. The previous studies the cephabacin biosynthesis were limited to a gene cluster that encodes the gene products responsible for the biosynthesis of the cephem nucleus. The long-term goal of this research is to elucidate the metabolic diversity and biosynthetic pathway of cephabacins and to design and/or discover new pharmacologically active compounds by engineering the cephabacin biosynthetic pathway in L. lactamgenus. In this study, we have cloned and sequenced a 24-kb fragment of a DNA locus upstream of the previously reported but incomplete putative ORF9 of L. lactamgenus. This contains three putative ORFs (the complete ORF9, ORF10, and ORF11) transcribed in the same direction and one putative ORF (ORF12) in the opposite direction. The isolated DNA locus extends the previously cloned part of the DNA locus containing the genes responsible for biosynthesis of the cephem nucleus up to 45 kb. The 42-kb fragment of the 45-kb gene cluster is located between a potential TATA box just upstream of the ORF11 and a termination loop just downstream of the previously reported bla gene. The complete ORF9 contains three nonribosomal peptide synthetase (NRPS) modules and one polyketide synthase (PKS) module and the ORF11 contains one NRPS module. The complete ORF9 also contains a putative thioesterase domain at the C-terminal end. We predicted the amino acid specificity of the four NRPSs by generating specificity binding pockets and expressed one of the NRPSs to confirm the amino acid specificity. The adenylation domain of the NRPS1, which is the last module of the NRPSs, showed significant amino acid specificity for L-arginine. These findings are in perfect agreement with the composition that was expected for the structure of cephabacins which contain an acetate residue, an L-arginine, and one to three L-alanines at the C-3' position of the cephem nucleus of cephabacins. The ORF10, encoding a putative ABC transporter which might be involved in conferring resistance against cephabacins, was identified between the complete ORF9 and the ORF11. Therefore, the complete ORF9, ORF10, ORF11 reported here and the other genes previously reported constitute an operon for the biosynthesis of cephabacins in L. lactamgenus. Based on our results, the biosynthetic pathways of acetate and elongated peptide moieties and a mechanism by which cephabacins are assembled by connecting the peptide moiety synthesized by the gene products of the complete ORF9 and the ORF11 to the C-3' position of the cephem nucleus synthesized by the gene products of pcbAB, pcbC, cefE, cefF, and cefD have been elucidated. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676571     DOI: 10.1006/mben.2001.0200

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  11 in total

1.  Identification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11.

Authors:  Wei Zhang; Yaoyao Li; Guoliang Qian; Yan Wang; Haotong Chen; Yue-Zhong Li; Fengquan Liu; Yuemao Shen; Liangcheng Du
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Analysis of a nonribosomal peptide synthetase gene from Alternaria brassicae and flanking genomic sequences.

Authors:  Thomas Guillemette; Adnane Sellam; Philippe Simoneau
Journal:  Curr Genet       Date:  2004-01-15       Impact factor: 3.886

3.  Indole-Induced Reversion of Intrinsic Multiantibiotic Resistance in Lysobacter enzymogenes.

Authors:  Yong Han; Yan Wang; Yameng Yu; Haotong Chen; Yuemao Shen; Liangcheng Du
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

4.  Evidence of an Unidentified Extracellular Heat-Stable Factor Produced by Lysobacter enzymogenes (OH11) that Degrade Fusarium graminearum PH1 Hyphae.

Authors:  Benard Omondi Odhiambo; Gaoge Xu; Guoliang Qian; Fengquan Liu
Journal:  Curr Microbiol       Date:  2017-02-17       Impact factor: 2.188

Review 5.  Bioactive natural products from Lysobacter.

Authors:  Yunxuan Xie; Stephen Wright; Yuemao Shen; Liangcheng Du
Journal:  Nat Prod Rep       Date:  2012-11       Impact factor: 13.423

6.  Involvement of both PKS and NRPS in antibacterial activity in Lysobacter enzymogenes OH11.

Authors:  Juan Zhang; Liangcheng Du; Fengquan Liu; Feifei Xu; Baishi Hu; Vittorio Venturi; Guoliang Qian
Journal:  FEMS Microbiol Lett       Date:  2014-06-03       Impact factor: 2.742

7.  Bacterial-Like Nonribosomal Peptide Synthetases Produce Cyclopeptides in the Zygomycetous Fungus Mortierella alpina.

Authors:  Jacob M Wurlitzer; Aleksa Stanišić; Ina Wasmuth; Sandra Jungmann; Dagmar Fischer; Hajo Kries; Markus Gressler
Journal:  Appl Environ Microbiol       Date:  2021-01-15       Impact factor: 4.792

8.  Facile method for site-specific gene integration in Lysobacter enzymogenes for yield improvement of the anti-MRSA antibiotics WAP-8294A and the antifungal antibiotic HSAF.

Authors:  Yan Wang; Guoliang Qian; Fengquan Liu; Yue-Zhong Li; Yuemao Shen; Liangcheng Du
Journal:  ACS Synth Biol       Date:  2013-08-27       Impact factor: 5.110

9.  Biosynthetic mechanism for sunscreens of the biocontrol agent Lysobacter enzymogenes.

Authors:  Yan Wang; Guoliang Qian; Yaoyao Li; Yansheng Wang; Yulan Wang; Stephen Wright; Yuezhong Li; Yuemao Shen; Fengquan Liu; Liangcheng Du
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Comparative genomics and metabolic profiling of the genus Lysobacter.

Authors:  Irene de Bruijn; Xu Cheng; Victor de Jager; Ruth Gómez Expósito; Jeramie Watrous; Nrupali Patel; Joeke Postma; Pieter C Dorrestein; Donald Kobayashi; Jos M Raaijmakers
Journal:  BMC Genomics       Date:  2015-11-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.